Jazz Pharmaceuticals plc (JAZZ) /
The revenue of Jazz Pharmaceuticals plc over the past 10 years
Chart Jazz Pharmaceuticals plc: revenue, fiscal 2016–2025 Open the chart →Jazz Pharmaceuticals plc reported revenue of $4.27B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $1.49B — up 187% over 9 years. Year over year, revenue rose every year. The largest one-year move was in fiscal 2021: up 31%, from $2.36B to $3.09B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $4.27B |
| 2024ended Dec 31, 2024 | $4.07B |
| 2023ended Dec 31, 2023 | $3.83B |
| 2022ended Dec 31, 2022 | $3.66B |
| 2021ended Dec 31, 2021 | $3.09B |
| 2020ended Dec 31, 2020 | $2.36B |
| 2019ended Dec 31, 2019 | $2.16B |
| 2018ended Dec 31, 2018 | $1.89B |
| 2017ended Dec 31, 2017 | $1.62B |
| 2016ended Dec 31, 2016 | $1.49B |
Fiscal years as Jazz Pharmaceuticals plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Jazz Pharmaceuticals plc
- The profitability of Jazz Pharmaceuticals plc
- The cash flow of Jazz Pharmaceuticals plc
- The debt of Jazz Pharmaceuticals plc
- All of Jazz Pharmaceuticals plc's financials, charted
Companies of a similar size
- RBCRBC BEARINGS INCORPORATED
- NBIXNEUROCRINE BIOSCIENCES INC
- SWKSTANLEY BLACK & DECKER, INC.
- PFGCPerformance Food Group Company
- ULSUL Solutions Inc.
Not investment advice. This page shows what Jazz Pharmaceuticals plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.